3Helix
PrivateLast Round
Seed Round
Aug 31, 2026
Total Funding Raised
$4.25M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
3Helix operates in Healthcare & Life Sciences and is based in Salt Lake City, Utah. Its latest recorded funding round was a Seed round in November 2023.
3Helix is a biotechnology company that develops proprietary collagen hybridizing peptide (CHP) technology for diagnostic, therapeutic, and personal care applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Fashion & Beauty, Medical Imaging
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
3Helix Comparables
Compare 3Helix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nordic Bioscience | 63% | |
| Ilex Life Sciences LLC | 62% | |
| PeptiMatrix | 62% |
For institutional investors. Book with your work email.
3Helix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Aug 31, 2026 | ||||
| Seed | Nov 2, 2023 | ||||
| Seed | Mar 30, 2022 | ||||
| Angel | Mar 18, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
3Helix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korea Investment Partners | Seed |
| Utah Innovation Fund | Seed |
| Johns Hopkins Technology Ventures | Seed |
| Altitude Lab | Seed, Seed Round |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 42% MoM.
- Aug 31, 2026
Raised $7.8M in Seed funding.
For institutional investors. Book with your work email.
3Helix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about 3Helix's valuation, stock price, and market status.
Is 3Helix a public or private company?
3Helix is a private company.
What is the current stock price of 3Helix?
3Helix is a private company, so its shares have no public market price. Caplight tracks 3Helix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is 3Helix worth (valuation)?
Valuation information for 3Helix is not publicly available.
Can I buy 3Helix stock?
3Helix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was 3Helix's last funding round?
3Helix's most recent funding round was Seed Round on August 31, 2026.
Who are the main investors in 3Helix?
Key investors in 3Helix include Korea Investment Partners, Utah Innovation Fund, Johns Hopkins Technology Ventures, Altitude Lab, National Institutes of Health (NIH).
Will 3Helix IPO soon?
No public IPO plans have been announced for 3Helix.
How can I track 3Helix secondary market activity?
Caplight tracks bids, offers, and trades in 3Helix's shares on secondary markets.